Usana Health Sciences Stock – Fundamental Analysis

Price
15.27
10/14/2026
Oct 1996
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 9/11/2026)

Balance Sheet Total Assets 742,915,000.00 ROE 78.92 %
Balance Sheet Total Equity 586,272,000.00 ROA 1.45 %
Cashflow Capital Expenditures -13,823,000.00 P/FCF 33.27
Cashflow Free Cash Flow 8,526,000.00 – –
Cashflow Operating Cash Flow 22,349,000.00 P/CF 12.69
Income Earnings per Share (diluted) 0.58 Div. Yield –
Income Net Income 10,760,000.00 P/E 26.33
Income Shares Outstanding 18,574,000.00 P/B 0.48
Income Total Revenue 925,257,000.00 P/S 0.31

Ratios calculated on: 10/14/2026

Company Description

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company has operations in 15 markets worldwide, where it distributes and sells its products by way of direct selling. The Company reports operations in two geographic regions: North America and Asia Pacific, which is further divided into three sub-regions; Southeast Asia/Pacific, Greater China, and North Asia. North America includes the United States, Canada, Mexico, and direct sales from the United States to the United Kingdom and the Netherlands. Southeast Asia/Pacific includes Australia, New Zealand, Singapore, Malaysia, and the Philippines; Greater China includes Hong Kong, Taiwan and China; and North Asia includes Japan and South Korea. The Company´s customer base consists of two types of customers: Associates and Preferred Customers. As of December 31, 2011, the Company had 222,000 active Associates and 64,000 active Preferred Customers worldwide.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.usanahealthsciences.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more